SCHEMBL1031152

SCHEMBL1031152

C/C(=N\O)c1ccc(-n2c3ccc(C(=O)c4ccccc4C)cc3c3cc(C(=O)c4ccccc4C)ccc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
HTT P42858 3/20 0.49
KDM4E B2RXH2 4/20 0.43
MAPT P10636 4/20 0.43
LMNA P02545 3/20 0.43
CA9 Q16790 6/20 0.42
HPGD P15428 3/20 0.42
GFER P55789 2/20 0.40
MAPK13 O15264 1/20 0.39
MAPK12 P53778 1/20 0.39
MAPK11 Q15759 1/20 0.39
MAPK14 Q16539 1/20 0.39
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1031154 1.00 ALDH1A1 (0.49) ALDH1A1HTTKDM4EMAPTLMNA
SCHEMBL1030850 0.88 ALDH1A1 (0.53) ALDH1A1HTTKDM4EMAPTLMNA
SCHEMBL13300260 0.86 ALDH1A1 (0.46) ALDH1A1HTTMAPTLMNAHPGD
SCHEMBL1029629 0.84 KDM4E (0.55) ALDH1A1HTTKDM4EMAPTLMNA
SCHEMBL1029628 0.84 KDM4E (0.55) ALDH1A1HTTKDM4EMAPTLMNA
SCHEMBL3020803 0.83 KDM4E (0.57) ALDH1A1HTTKDM4EMAPTLMNA
SCHEMBL3020806 0.83 KDM4E (0.57) ALDH1A1HTTKDM4EMAPTLMNA
SCHEMBL29895750 0.82 KDM4E (0.67) ALDH1A1HTTKDM4EMAPTLMNA
SCHEMBL22460842 0.82 KDM4E (0.67) ALDH1A1HTTKDM4EMAPTLMNA
SCHEMBL29616531 0.82 KDM4E (0.67) ALDH1A1HTTKDM4EMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8940464-B2 Oxime ester photoinitiators BASF SE (DE) 2015-01-27 US disclosed
EP-2172455-B1 Oxime ester photoinitiators BASF SE (DE) 2011-01-19 EP disclosed
EP-2172455-A1 Oxime ester photoinitiators BASF SE (DE) 2010-04-07 EP disclosed
US-20090087759-A1 Oxime Ester Photoinitiators BASF SE (DE) 2009-04-02 US disclosed
EP-1957457-A1 OXIME ESTER PHOTOINITIATORS Ciba Holding Inc. (CH) 2008-08-20 EP disclosed
WO-2007062963-A1 OXIME ESTER PHOTOINITIATORS CIBA HOLDING INC. (CH) 2007-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090087759-A1 Oxime Ester Photoinitiators CBR3, CCNE2, ALKBH2 ALDH1A1 1219/4885HTT 3395/4885KDM4E 814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.